Explore a 39-minute panel discussion from ICML 2023 on fostering impactful AI models in drug discovery. Gain insights from industry experts and researchers as they address challenges in implementing academic research in real-world settings, discuss ways to support academia, examine the lack of open datasets, and explore methods for effective model evaluation and benchmarking. Learn about the gap between research results and real-world value in drug discovery programs, and hear perspectives from leaders at Recursion Pharma, Merck, GSK, and ETH Zurich. Engage with the open Q&A session to further understand the complexities of AI applications in pharmaceutical research and development.